Drug Type Small molecule drug |
Synonyms |
Mechanism HIV envelope protein gp120 inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H18F3N5O2S |
InChIKeyBILBXEUAJZPBIW-AWEZNQCLSA-N |
CAS Registry2411819-82-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Preclinical | US | 27 Feb 2020 |